Expression of the signal transduction molecule ζ in peripheral and tumour-associated lymphocytes in Hodgkin's disease in relation to the Epstein-Barr virus status of the tumour cells

British Journal of Haematology

Volumn 116, Issue 4, 2002, Pages 765-773

  Sjöberg, Jan ^a   Andersson, Margareta ^a   Garcia, Carlos ^a   Palucka, Karolina A ^a   Björkholm, Magnus ^a   Porwit MacDonald, Anja ^a   Pisa, Pavel ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CD16f; CD3f; Epstein Barr virus; Hodgkin's disease; Immunobiology

Indexed keywords

CD16 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; PROTEIN; SIGNAL TRANSDUCTION MOLECULE ZETA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CELL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; EPSTEIN BARR VIRUS; FEMALE; FLOW CYTOMETRY; HODGKIN DISEASE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REED STERNBERG CELL; REGULATORY MECHANISM; SCHOOL CHILD; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; VIRUS INFECTION;

ADOLESCENT; ADULT; ANTIGENS, CD3; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CHILD; FEMALE; FLOW CYTOMETRY; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTES; MALE; MIDDLE AGED; RECEPTORS, IGG; REED-STERNBERG CELLS;

EID: 0036125076     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0007-1048.2002.03342.x     Document Type: Article

References (49)

1. Tissue eosinophilia in relation to immunopathological and clinical characteristics in Hodgkin's disease
2. Genetic reconstitution of the T cell receptor (TcR) alpha/beta heterodimer restores the association of CD3 zeta 2 with the TcR/CD3 complex
3. Immune-deficiency in Hodgkin's disease (HD): A study of patients and healthy relatives in families with multiple cases
4. The B7/BB1 antigen is expressed by Reed-Sternberg cells of Hodgkin's disease and contributes to the stimulating capacity of Hodgkin's disease-derived cell lines
5. Distribution of T-lymphocyte subsets in Hodgkin's disease characterized by monoclonal antibodies
6. All infiltrating T-lymphocytes in Hodgkin's disease express immunohistochemically detectable T-cell receptor zeta-chains in situ
7. Association of an interleukin abnormality with the T cell defect in Hodgkin's disease
8. Local suppression of Epstein-Barr virus (EBV) -specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease
9. Expression of signal-transducing zeta chain in peripheral blood T cells and natural killer cells in patients with Hodgkin's disease in different phases of the disease
10. Tumour-induced suppression of antitumour reactivity and depression of TCRzeta expression in tumour-draining lymph node lymphocytes: Possible relationship to the Th2 pathway
11. Deficiency of lymphocyte antigen recognition in Hodgkin's disease
12. Hodgkin's disease: A tumour with disturbed immunological pathways
13. Requirements for cell surface expression of the human TCR/CD3 complex in non-T cells
14. Impaired expression and function of signal-transducing zeta chains in peripheral T cells and natural killer cells in patients with prostate cancer
15. High incidence of Epstein-Barr virus genomes in Hodgkin's disease
16. The cytoplasmic domain of the T cell receptor zeta chain is sufficient to couple to receptor-associated signal transduction pathways
17. Functional characterization of a signal transducing motif present in the T cell antigen receptor zeta chain
18. The implications of subunit interactions for the structure of the T cell receptor-CD3 complex
19. Hydrogen peroxide secreted by tumour-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumour-specific T cell- and natural killer cell-mediated cytotoxicity
20. Delineation of a T-cell activation motif required for binding of protein tyrosine kinases containing tandem SH2 domains
21. Clinical significance of decreased zeta chain expression in peripheral blood lymphocytes of patients with head and neck cancer
22. Antigen presenting phenotype of Hodgkin Reed-Sternberg cells: Analysis of the HLA class I processing pathway and the effects of interleukin-10 on Epstein-Barr virus-specific cytotoxic T-cell recognition
23. Immunologic profile in patients with Hodgkin's disease in complete remission
24. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting
25. Transmembrane signalling through the T-cell-receptor-CD3 complex
26. Correlation between disease activity and T-cell CD3 zeta chain expression in a B-cell lymphoma
27. Decreased expression of signal-transducing CD3 zeta chains in T cells from the joints and peripheral blood of rheumatoid arthritis patients
28. Lack of restricted T-cell receptor beta-chain variable region (V beta) usage of reactive T-lymphocytes in Hodgkin's disease
29. Building a multichain receptor: Synthesis, degradation, and assembly of the T-cell antigen receptor
30. In vivo expression of the B7 costimulatory molecule by subsets of antigen-presenting cells and the malignant cells of Hodgkin's disease
31. Oxidative stress by tumour-derived macrophages suppresses the expression of CD3 zeta chain of T-cell receptor complex and antigen-specific T-cell responses
32. Analysis of major histocompatibility complex class I expression on Reed-Sternberg cells in relation to the cytotoxic T-cell response in Epstein-Barr virus-positive and -negative Hodgkin's disease
33. Lymphocyte apoptosis induced by Fas ligand-expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumour-associated lymphocytes
34. On the pathological changes in Hodgkin's disease with especial reference to its relation to tuberculosis
35. Absent or low expression of the zeta chain in T cells at the tumour site correlates with poor survival in patients with oral carcinoma
36. T cells from patients with Hodgkin's disease have a defective T-cell receptor zeta chain expression that is reversible by T-cell stimulation with CD3 and CD28
37. Reactivation of Epstein-Barr virus-specific cytotoxic T cells by in vitro stimulation with the autologous lymphoblastoid cell line
38. Sequence requirements for induction of cytolysis by the T cell antigen/Fc receptor zeta chain
39. Isolation of Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes that lyse Reed-Sternberg cells: Implications for immune-mediated therapy of EBV+ Hodgkin's disease
40. ZAP-70 association with T cell receptor zeta (TCRzeta): Fluorescence imaging of dynamic changes upon cellular stimulation
41. Failure to synthesize the T cell CD3-zeta chain: Structure and function of a partial T cell receptor complex
42. Variable expression of CD3-zeta chain in tumour-infiltrating lymphocytes (TIL) derived from renal-cell carcinoma: Relationship with TIL phenotype and function
43. Circulating CD8 T lymphocytes in human immunodeficiency virus-infected individuals have impaired function and downmodulate CD3 zeta, the signaling chain of the T-cell receptor complex
44. Lymphocyte abnormalities predicting a poor prognosis in Hodgkin's disease. A long-term follow-up
45. Degradation of T cell receptor (TCR)-CD3-zeta complexes after antigenic stimulation
46. Expression of B7-2 (CD86) molecules by Reed-Sternberg cells of Hodgkin's disease
47. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease
48. Role of the zeta chain in the expression of the T cell antigen receptor: Genetic reconstitution studies